Fujifilm Invests $1.6 Billion for Cell Culture Expansion

Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Japan’s Fujifilm will invest about $850 million to accelerate the growth of...
Japan’s Fujifilm will invest about $850 million to accelerate the growth of its core bio CDMO subsidiary Fujifilm Diosynth Biotechnologies by expanding plants in the US and UK. Initial engineering studies are underway and the projects are due to begin operating by late 2023. (c) Fujifilm Diosynth Biotechnologies

Most of the funds will be funneled into the Japanese company’s Hillerød, Denmark, site but College Station, Texas, will also benefit. The upgrade will add 450 new jobs at Hillerød, bringing the total number of employees to 1,055.

Plans for investment in production equipment center on increasing capability for GMP batch manufacturing with the addition of eight 20,000-liter bioreactors and two downstream processing streams.

When the project is completed, the Hillerød business expects to be Europe’s largest end-to-end CDMO with 20 bioreactors of 20,000-l capacity for drug substance production.   

Fujifilm said the upgrade of the Danish site will also focus on sustainability, for example replacing an electric boiler with one powered by natural gas. The Diosynth Biotechnologies arm also will invest in technologies to cut water consumption.

Teiichi Goto, president and CEO of Fujifilm, said the further expansion of the bio CDMO business fits with the company’s strategy of leveraging both capital investment and technological innovation to meet the rapidly growing demand for high volume production of biopharmaceuticals.

By its own account, Fujifilm has invested more than $7.1 billion to expand its CDMO business over the past few years – the sum includes the acquisition of the Hillerød site from Biogen for $890 milion in August 2019. The healthcare business unit is now its largest in terms of sales revenue and operating profit.

Author: Dede Williams, Freelance Journalist

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.